HUP0303963A2 - Figyelemhiányban/hiperaktivitásban szenvedő gyermekek tanulási rendellenességeinek megelőzésére vagy kezelésére szolgáló kompozíció - Google Patents
Figyelemhiányban/hiperaktivitásban szenvedő gyermekek tanulási rendellenességeinek megelőzésére vagy kezelésére szolgáló kompozícióInfo
- Publication number
- HUP0303963A2 HUP0303963A2 HU0303963A HUP0303963A HUP0303963A2 HU P0303963 A2 HUP0303963 A2 HU P0303963A2 HU 0303963 A HU0303963 A HU 0303963A HU P0303963 A HUP0303963 A HU P0303963A HU P0303963 A2 HUP0303963 A2 HU P0303963A2
- Authority
- HU
- Hungary
- Prior art keywords
- prevention
- treatment
- composition
- attention deficit
- learning disorders
- Prior art date
Links
- 208000020358 Learning disease Diseases 0.000 title 1
- 230000006735 deficit Effects 0.000 title 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title 1
- 208000035475 disorder Diseases 0.000 title 1
- 201000003723 learning disability Diseases 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/438—The ring being spiro-condensed with carbocyclic or heterocyclic ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
IT2001RM000218A ITRM20010218A1 (it) | 2001-04-23 | 2001-04-23 | Composizione per la prevenzione o il trattamento dei disturbi dell'apprendimento in bambini affetti da deficit dell'attenzione ed iperattivi |
PCT/IT2001/000430 WO2002085341A2 (en) | 2001-04-23 | 2001-08-03 | Composition, containing carnitine and huperzin for the preventionor treatment of learning disorders in children suffering from attention deficit/hyperactive disorder |
Publications (2)
Publication Number | Publication Date |
---|---|
HUP0303963A2 true HUP0303963A2 (hu) | 2004-04-28 |
HUP0303963A3 HUP0303963A3 (en) | 2005-04-28 |
Family
ID=11455486
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU0303963A HUP0303963A3 (en) | 2001-04-23 | 2001-08-03 | Composition for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder |
Country Status (12)
Country | Link |
---|---|
US (1) | US20040058947A1 (hu) |
EP (1) | EP1383579B1 (hu) |
AT (1) | ATE291468T1 (hu) |
CA (1) | CA2436240A1 (hu) |
DE (1) | DE60109651T2 (hu) |
ES (1) | ES2237591T3 (hu) |
HU (1) | HUP0303963A3 (hu) |
IT (1) | ITRM20010218A1 (hu) |
MX (1) | MXPA03009631A (hu) |
PL (1) | PL367613A1 (hu) |
PT (1) | PT1383579E (hu) |
WO (1) | WO2002085341A2 (hu) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
GB2390055B (en) | 2002-03-22 | 2005-09-07 | Cypher Science Internat Ltd | A marking apparatus |
CN100441200C (zh) * | 2004-11-26 | 2008-12-10 | 谢德隆 | 石杉碱甲、乙复合成分的蛇足石杉提取物及其制备方法 |
GB201205856D0 (en) * | 2012-04-02 | 2012-05-16 | Randall Jeremy A P | Food supplement to support brain function |
CN102702101B (zh) * | 2012-05-23 | 2016-04-06 | 长沙市惠瑞生物科技有限公司 | 一种从千层塔中提取石杉碱甲的方法 |
CN103667072B (zh) * | 2013-09-27 | 2016-04-13 | 浙江工业大学 | 一种蛇足石杉内生真菌及其在制备8α,15α-环氧化石杉碱甲的应用 |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP0979092A2 (en) * | 1997-04-29 | 2000-02-16 | Kenneth Blum, Inc. | Allelic polygene diagnosis of reward deficiency syndrome and treatment |
US5869528A (en) * | 1997-07-22 | 1999-02-09 | Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. | Therapeutical method for the treatment of attention-deficit/hyperactive disorders |
US6964969B2 (en) * | 2001-04-19 | 2005-11-15 | Mccleary Edward Larry | Composition and method for treating impaired or deteriorating neurological function |
-
2001
- 2001-04-23 IT IT2001RM000218A patent/ITRM20010218A1/it unknown
- 2001-08-03 PT PT01961133T patent/PT1383579E/pt unknown
- 2001-08-03 ES ES01961133T patent/ES2237591T3/es not_active Expired - Lifetime
- 2001-08-03 EP EP01961133A patent/EP1383579B1/en not_active Expired - Lifetime
- 2001-08-03 DE DE60109651T patent/DE60109651T2/de not_active Expired - Fee Related
- 2001-08-03 AT AT01961133T patent/ATE291468T1/de not_active IP Right Cessation
- 2001-08-03 CA CA002436240A patent/CA2436240A1/en not_active Abandoned
- 2001-08-03 MX MXPA03009631A patent/MXPA03009631A/es unknown
- 2001-08-03 HU HU0303963A patent/HUP0303963A3/hu unknown
- 2001-08-03 US US10/250,359 patent/US20040058947A1/en not_active Abandoned
- 2001-08-03 PL PL01367613A patent/PL367613A1/xx unknown
- 2001-08-03 WO PCT/IT2001/000430 patent/WO2002085341A2/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
DE60109651D1 (de) | 2005-04-28 |
ITRM20010218A1 (it) | 2002-10-23 |
MXPA03009631A (es) | 2004-06-30 |
ATE291468T1 (de) | 2005-04-15 |
HUP0303963A3 (en) | 2005-04-28 |
EP1383579B1 (en) | 2005-03-23 |
ES2237591T3 (es) | 2005-08-01 |
PL367613A1 (en) | 2005-03-07 |
DE60109651T2 (de) | 2006-04-27 |
CA2436240A1 (en) | 2002-10-31 |
WO2002085341A2 (en) | 2002-10-31 |
US20040058947A1 (en) | 2004-03-25 |
PT1383579E (pt) | 2005-06-30 |
ITRM20010218A0 (it) | 2001-04-23 |
WO2002085341A3 (en) | 2003-05-08 |
EP1383579A2 (en) | 2004-01-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA03007960A (es) | Compuestos y metodos para el tratamiento de desordenes urogenitales. | |
IL175055A0 (en) | Combinations useful for the treatment of neuronal disorders | |
HK1152243A1 (en) | Vegf for use in the treatment of central nervous system disorders vegf | |
PL1644021T3 (pl) | Sposoby i kompozycje do leczenia zaburzeń żołądkowo-jelitowych | |
ZA200401004B (en) | Combination for the treatment of inflammatory disorders | |
IL162838A0 (en) | Compositions and methods for prevention and treatment peptide-of amyloid- related disorders | |
ZA200607433B (en) | Methods and compositions for the treatment of gastroin-testinal disorders | |
AU2003233583A8 (en) | Oral lactoferrin in the treatment of respiratory disorders | |
AU2003249983A8 (en) | Piperidines useful for the treatment of central nervous system disorders | |
MXPA03006043A (es) | Metodos que emplean y composiciones que contienen moleculas asociadas en placa para la prevencion y el tratamiento de la aterosclerosis. | |
ZA200702421B (en) | Iron complex for use in the treatment and/or prevention of nutritional disorders | |
IL155589A0 (en) | Novel amidoalkyl-piperidine and amidoalkyl-piperazine derivatives useful for the treatment of nervous system disorders | |
EP1356278A4 (en) | METHODS AND COMPOSITIONS FOR IDENTIFYING AND TREATING NEURODEGENERATIVE DISORDERS | |
EE200100205A (et) | Karnitiinide ning resveratrooli kombinatsioon tserebraalsete ning vananemisest tingitud haiguste ennetamiseks või raviks | |
EP1499309A4 (en) | PREVENTION AND TREATMENT OF FUNCTIONAL SOMATIC DISEASES, INCLUDING STRESS-BASED DISEASES | |
AU2003255993A1 (en) | Diazabicyclic compounds useful in the treatment of cns and other disorders | |
HK1065486A1 (en) | Carbamate compounds for use in preventing or treating neurodegenerative disorders | |
WO2003039490A9 (en) | Compositions and methods for diagnosing and treating mental disorders | |
HUP0303963A3 (en) | Composition for the prevention or treatment of learning disorders in children suffering from attention deficit/hyperactive disorder | |
GB0128674D0 (en) | Treatment of sleep disorders and the like | |
NO20012106L (no) | Middel for behandling av forstyrrelser i benmetabolismen | |
ITRM990707A0 (it) | Composizione per la prevenzione e/o il trattamento di disturbi dovutiad un alterato metabolismo dei lipidi, che comprende propionil l-carni | |
PL351554A1 (en) | Osanetant in the treatment of mood disorders | |
EP1471818A4 (en) | METHOD AND COMPOSITIONS FOR TREATING HEMATOLOGICAL DISEASES USING 131, 148, 199, 12303, 13906, 15513, 17822, 302, 5677, 194, 14393, 28059, 7366, 12212, 1981, 261, 12416, 270, 1410, 137 , 1871, 13051, 1847, 1849, 15402, 340, 10217, 837, 1761, 8990 OR 13249 MOLECULES | |
HUP0204209A3 (en) | Composition for the prevention and/or treatment of lipid metabolism disorders and allergic forms |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FD9A | Lapse of provisional protection due to non-payment of fees |